Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review

BACKGROUND: Global annual cancer incidence is forecast to rise to 27.5 M by 2040, a 62% increase from 2018. For most cancers, prevention and early detection are the most effective ways of reducing mortality. This study maps trials in cancer screening, prevention, and early diagnosis (SPED) to identi...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Dowd, Emma L., Merriel, Samuel W. D., Cheng, Vinton W. T., Khan, Sam, Howells, Lynne M., Gopal, Dipesh P., Roundhill, Elizabeth A., Brennan, Paul M., Crosbie, Philip A. J., Neal, Richard D., Brown, Karen, Crosbie, Emma J., Baldwin, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476302/
https://www.ncbi.nlm.nih.gov/pubmed/37667231
http://dx.doi.org/10.1186/s12885-023-11300-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476302/
https://www.ncbi.nlm.nih.gov/pubmed/37667231
http://dx.doi.org/10.1186/s12885-023-11300-8

Ejemplares similares